Conversely, biomarkers like GFAP show promise in distinguishing stroke subtypes, predicting hemorrhagic transformation and aids in distinguishing between hemorrhagic and ischemic strokes based on the extent of blood-brain barrier disruption [51]. This evidence concerns the gene GFAP and ischemic stroke.